PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Radiation Oncology Journal10.3857/roj.2015.33.2.1172015332117Early treatment volume reduction rate as a prognostic factor in patients treated with chemoradiotherapy for limited stage small cell lung cancerJoohwan Lee, Jeongshim Lee, Jinhyun Choi, Jun Won Kim, Jaeho Cho, Chang Geol Leehttp://synapse.koreamed.org/pdf/10.3857/roj.2015.33.2.117, http://synapse.koreamed.org/DOIx.php?id=10.3857/roj.2015.33.2.117, http://www.e-roj.org/upload/pdf/roj-33-117.pdf
Lung Cancer10.1016/s0169-5002(19)30249-12019127S85Treatment patterns and outcomes for limited stage small cell lung cancer treated with chemoradiotherapyD. Sim, A. Pascoe, K. Fowerakerhttps://api.elsevier.com/content/article/PII:S0169500219302491?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500219302491?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(13)70265-4201380S19-S2044P INVESTIGATING GENDER AS PROGNOSTIC FACTOR IN PATIENTS WITH LIMITED DISEASE SCLC TREATED WITH CHEMORADIOTHERAPYF. Manapovhttps://api.elsevier.com/content/article/PII:S0169500213702654?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500213702654?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(96)84340-61995133349Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: A prospective phase III randomized study of the Southwest Oncology Grouphttps://api.elsevier.com/content/article/PII:0169500296843406?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500296843406?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(03)92025-3200341S105P-56 Early concurrent normo- and hyperfractionated chemoradiotherapy in limited small cell lung cancer (LSCLC). Experience with 34 treated patientsZdenek Skacel, Miloslav Marel, Roman Pajdlhauser, Bela Malinova, Jana Prausova, Katerina Kosatovahttps://api.elsevier.com/content/article/PII:S0169500203920253?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500203920253?httpAccept=text/plain
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2015.07.16072015933E415-E416Treatment Response as Prognostic Factor in Patients Treated With Chemoradiation Therapy for Limited-Stage Small Cell Lung CancerJ. Lee, J. Choi, J. Lee, C.G. Leehttps://api.elsevier.com/content/article/PII:S036030161502338X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S036030161502338X?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(96)84364-91995133354-355Pre-treatment prognostic factors in patients with Stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapyhttps://api.elsevier.com/content/article/PII:0169500296843649?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500296843649?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(11)70217-3201171S40-S4180PD PROGNOSTIC IMPORTANCE OF GROSS TUMOR VOLUME DEFINED BY UTILIZING 18-FDG-PET/CT IN STAGE IIIB NON-SMALL CELL LUNG CARCINOMA TREATED WITH DEFINITIVE CHEMORADIOTHERAPYC. Parlak, B. Pehlivan, E. Oymak, S. Topuk, E. Topkanhttps://api.elsevier.com/content/article/PII:S0169500211702173?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500211702173?httpAccept=text/plain
Lung Cancer10.1007/0-387-22652-4_102003186-206Treatment of Limited-Stage Small Cell Lung CancerRitsuko Komakihttp://link.springer.com/content/pdf/10.1007/0-387-22652-4_10
Lung Cancer10.1016/0169-5002(95)00480-o199513121-30Pre-treatment prognostic factors in patients with Stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapyBranislav Jeremic, Yuta Shibamotohttps://api.elsevier.com/content/article/PII:016950029500480O?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016950029500480O?httpAccept=text/plain